Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Therese Standal

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Experimental Oncology|October 21, 2004
Role of osteopontin in adhesion, migration, cell survival and bone remodelingTherese Standal, Magne Borset, Anders Sundan
Journal of Leukocyte Biology|September 2, 2020
Molecular interactions and functions of IL-32Kristin Roseth Aass, Martin H Kastnes, Therese Standal
Blood Reviews|December 8, 2019
Why do myeloma patients have bone disease? A historical perspectiveMagne Børset, Anders Sundan, Anders Waage, et al.
American Journal of Hematology|March 13, 2012
Secondary hyperparathyroidism but stable bone-mineral density in patients with chronic myeloid leukemia treated with imatinibSofia Jönsson, Therese Standal, Bob Olsson, et al.
Medical Oncology (Northwood, London, England)|February 17, 2007
Bone disease in multiple myelomaØyvind Hjertner, Therese Standal, Magne Børset, et al.
Journal of Bone and Mineral Metabolism|October 14, 2011
Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitroSofia Jönsson, Henrik Hjorth-Hansen, Bob Olsson, et al.
Plos One|March 14, 2015
Osteogenic differentiation of human mesenchymal stem cells in mineralized alginate matricesMarita Westhrin, Minli Xie, Magnus Ø Olderøy, et al.
Blood|December 2, 2006
HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myelomaTherese Standal, Niels Abildgaard, Unn-Merete Fagerli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 13, 2010
CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesisNikolai N Nørgaard, Toril Holien, Sofia Jönsson, et al.
Blood|October 24, 2002
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factorTherese Standal, Magne Borset, Stig Lenhoff, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Experimental Oncology|October 21, 2004
Role of osteopontin in adhesion, migration, cell survival and bone remodelingTherese Standal, Magne Borset, Anders Sundan
Journal of Leukocyte Biology|September 2, 2020
Molecular interactions and functions of IL-32Kristin Roseth Aass, Martin H Kastnes, Therese Standal
Blood Reviews|December 8, 2019
Why do myeloma patients have bone disease? A historical perspectiveMagne Børset, Anders Sundan, Anders Waage, et al.
American Journal of Hematology|March 13, 2012
Secondary hyperparathyroidism but stable bone-mineral density in patients with chronic myeloid leukemia treated with imatinibSofia Jönsson, Therese Standal, Bob Olsson, et al.
Medical Oncology (Northwood, London, England)|February 17, 2007
Bone disease in multiple myelomaØyvind Hjertner, Therese Standal, Magne Børset, et al.
Journal of Bone and Mineral Metabolism|October 14, 2011
Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitroSofia Jönsson, Henrik Hjorth-Hansen, Bob Olsson, et al.
Plos One|March 14, 2015
Osteogenic differentiation of human mesenchymal stem cells in mineralized alginate matricesMarita Westhrin, Minli Xie, Magnus Ø Olderøy, et al.
Blood|December 2, 2006
HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myelomaTherese Standal, Niels Abildgaard, Unn-Merete Fagerli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 13, 2010
CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesisNikolai N Nørgaard, Toril Holien, Sofia Jönsson, et al.
Blood|October 24, 2002
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factorTherese Standal, Magne Borset, Stig Lenhoff, et al.
Pageof 5